Drugs / Week 0 and Week 2:
Solumedrol (100 mg) IV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02260934 Background | Jul 2015 → Mar 2018 | lupus nephritis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Week 0 and Week 2: Solumedrol (100 mg) IV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02260934 ↗ |